Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Fabbri

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
Neuropsychobiology|August 18, 2015
Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristicsGiuseppe Plazzi, Chiara Fabbri, Fabio Pizza, et al.
Clinical Neuropharmacology|June 27, 2023
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case ReportMauro Scala, Laura Biondi, Alessandro Serretti, et al.
International Journal of Psychiatry in Clinical Practice|September 18, 2025
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectivenessMauro Scala, Giuseppe Fanelli, Chiara Fabbri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 5, 2013
Pharmacogenetics in major depression: a comprehensive meta-analysisTomihisa Niitsu, Chiara Fabbri, Francesco Bentini, et al.
International Clinical Psychopharmacology|July 21, 2017
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsFilippo Corponi, Alessandro Serretti, Stuart Montgomery, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 30, 2014
A model to investigate SNPs' interaction in GWAS studiesEnrico Cocchi, Antonio Drago, Chiara Fabbri, et al.
Psychiatry Research|March 26, 2022
COVID-19 hospitalization rates in individuals with substance or alcohol use disordersRaimondo Maria Pavarin, Chiara Fabbri, Diana De Ronchi
Journal of Clinical Psychopharmacology|September 8, 2023
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II DepressionMauro Scala, Laura Biondi, Chiara Fabbri, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2014
Understanding the pharmacogenetics of selective serotonin reuptake inhibitorsChiara Fabbri, Alessandro Minarini, Tomihisa Niitsu, et al.
International Clinical Psychopharmacology|February 22, 2020
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatmentChiara Fabbri, Stuart Montgomery, Cathryn M Lewis, et al.
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
Neuropsychobiology|August 18, 2015
Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristicsGiuseppe Plazzi, Chiara Fabbri, Fabio Pizza, et al.
Clinical Neuropharmacology|June 27, 2023
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case ReportMauro Scala, Laura Biondi, Alessandro Serretti, et al.
International Journal of Psychiatry in Clinical Practice|September 18, 2025
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectivenessMauro Scala, Giuseppe Fanelli, Chiara Fabbri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 5, 2013
Pharmacogenetics in major depression: a comprehensive meta-analysisTomihisa Niitsu, Chiara Fabbri, Francesco Bentini, et al.
International Clinical Psychopharmacology|July 21, 2017
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsFilippo Corponi, Alessandro Serretti, Stuart Montgomery, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 30, 2014
A model to investigate SNPs' interaction in GWAS studiesEnrico Cocchi, Antonio Drago, Chiara Fabbri, et al.
Psychiatry Research|March 26, 2022
COVID-19 hospitalization rates in individuals with substance or alcohol use disordersRaimondo Maria Pavarin, Chiara Fabbri, Diana De Ronchi
Journal of Clinical Psychopharmacology|September 8, 2023
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II DepressionMauro Scala, Laura Biondi, Chiara Fabbri, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2014
Understanding the pharmacogenetics of selective serotonin reuptake inhibitorsChiara Fabbri, Alessandro Minarini, Tomihisa Niitsu, et al.
International Clinical Psychopharmacology|February 22, 2020
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatmentChiara Fabbri, Stuart Montgomery, Cathryn M Lewis, et al.
Pageof 22